Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma

FEBS Letters

Volumn 588, Issue 3, 2014, Pages 503-508

  Wang, Hui ^a   Wang, Bin ^b   Liao, Qing ^b   An, Hongying ^b   Li, Weidong ^a   Jin, Xuejun ^a   Cui, Shuzhong ^a   Zhao, Liang ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Neoplasm metastasis; Rho GDP dissociation inhibitor alpha; Signal transduction

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; SMALL INTERFERING RNA;

ADULT; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR VOLUME; UPREGULATION;

HEPATOCELLULAR CARCINOMA; NEOPLASM METASTASIS; RHO GDP-DISSOCIATION INHIBITOR ALPHA; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; RAC GTP-BINDING PROTEINS; RHO GTP-BINDING PROTEINS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84892820960     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.12.016     Document Type: Article

References (29)

1. K. Okuda Hepatocellular carcinoma J. Hepatol. 32 2000 225 237 (Pubitemid 30123637)
2. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N. Engl. J. Med. 340 1999 745 750 (Pubitemid 29114292)
3. M. Chiriva-Internati, F. Grizzi, M.S. Wachtel, M. Jenkins, R. Ferrari, E. Cobos, and E.E. Frezza Biological treatment for liver tumor and new potential biomarkers Dig. Dis. Sci. 53 2008 836 843 (Pubitemid 351317064)
4. B. Olofsson Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling Cell Signal. 11 1999 545 554 (Pubitemid 29255886)
5. A. Dovas, and J.R. Couchman RhoGDI: multiple functions in the regulation of Rho family GTPase activities Biochem. J. 390 2005 1 9 (Pubitemid 41192225)
6. J.J. Gildea et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer Cancer Res. 62 2002 6418 6423 (Pubitemid 35364098)
7. W.G. Jiang, G. Watkins, J. Lane, G.H. Cunnick, A. Douglas-Jones, K. Mokbel, and R.E. Mansel Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers Clin. Cancer Res. 9 2003 6432 6440 (Pubitemid 38031830)
8. M.B. Jones, H. Krutzsch, H. Shu, Y. Zhao, L.A. Liotta, E.C. Kohn, and E.F. Petricoin 3rd Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer Proteomics 2 2002 76 84 (Pubitemid 34273101)
9. B. Kasper, N. Tidow, D. Grothues, and K. Welte Differential expression and regulation of GTPases (RhoA and Rac2) and GDIs (LyGDI and RhoGDI) in neutrophils from patients with severe congenital neutropenia Blood 95 2000 2947 2953 (Pubitemid 30235908)
10. L. Zhao, H. Wang, X. Sun, and Y. Ding Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma FEBS J. 277 2010 4195 4204
11. L. Zhao, H. Wang, J. Li, Y. Liu, and Y. Ding Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer J. Proteome Res. 7 2008 3994 4003
12. J. Ding et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA Nat. Cell Biol. 12 2010 390 399
13. S.J. Ding, Y. Li, X.X. Shao, H. Zhou, R. Zeng, Z.Y. Tang, and Q.C. Xia Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials Proteomics 4 2004 982 994 (Pubitemid 38445958)
14. S.J. Ding et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis Mol. Cell Proteomics 3 2004 73 81
15. L. Zhao et al. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1 Gut 59 2010 1226 1235
16. L.S. Ramagli Quantifying protein in 2-D PAGE solubilization buffers Methods Mol. Biol. 112 1999 99 103
17. D. Coppola, M. Szabo, D. Boulware, P. Muraca, M. Alsarraj, A.F. Chambers, and T.J. Yeatman Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin. Cancer Res. 10 2004 184 190 (Pubitemid 38114178)
18. C.D. Nobes, and A. Hall Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Cell 81 1995 53 62
19. S. Etienne-Manneville, and A. Hall Rho GTPases in cell biology Nature 420 2002 629 635 (Pubitemid 36764489)
20. J. Faure, and M.C. Dagher Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI) Biochimie 83 2001 409 414 (Pubitemid 32466054)
21. C. DerMardirossian, and G.M. Bokoch GDIs: central regulatory molecules in Rho GTPase activation Trends Cell Biol. 15 2005 356 363 (Pubitemid 40943524)
22. T. Ueda, A. Kikuchi, N. Ohga, J. Yamamoto, and Y. Takai Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein J. Biol. Chem. 265 1990 9373 9380
23. Y. Fukumoto, K. Kaibuchi, Y. Hori, H. Fujioka, S. Araki, T. Ueda, A. Kikuchi, and Y. Takai Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins Oncogene 5 1990 1321 1328
24. T. Yamashita et al. Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer Pharmazie 67 2012 253 255
25. Y. Zhu, R. Tummala, C. Liu, N. Nadiminty, W. Lou, C.P. Evans, Q. Zhou, and A.C. Gao RhoGDIalpha suppresses growth and survival of prostate cancer cells Prostate 72 2012 392 398
26. W.F. Chiang et al. Overexpression of Rho GDP-dissociation inhibitor alpha predicts poor survival in oral squamous cell carcinoma Oral Oncol. 47 2011 452 458
27. H. Ronneburg, P.N. Span, E. Kantelhardt, A. Dittmer, D. Schunke, H.J. Holzhausen, F.C. Sweep, and J. Dittmer Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer Int. J. Oncol. 36 2010 379 386
28. T. Goto et al. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers Oncol. Rep. 15 2006 1265 1271
29. B. Zhang, Y. Zhang, M.C. Dagher, and E. Shacter Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis Cancer Res. 65 2005 6054 6062 (Pubitemid 40994389)